Camzyos — Total Revenues
Bristol-Myers Squibb Camzyos — Total Revenues increased by 13.8% to $296.00M in Q3 2025 compared to the prior quarter. Year-over-year, this metric grew by 89.7%, from $156.00M to $296.00M. Over 2 years (FY 2022 to FY 2024), Camzyos — Total Revenues shows an upward trend with a 400.8% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
How to read this metric
An increase indicates successful market penetration, strong physician adoption, and effective commercial execution for this specific therapy. A decrease may signal increased competition, pricing pressure, or slower-than-expected patient uptake.
Detailed definition
This metric represents the total global net sales generated from the commercialization of Camzyos, a specialized therape...
Peer comparison
Comparable to revenue metrics for specific blockbuster or specialty drugs at other large-cap pharmaceutical companies, often evaluated based on launch trajectory and peak sales potential.
bmy_segment_camzyos_total_revenuesHistorical Data
| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $0.00 | $0.00 | $0.00 | $3.00M | $5.00M | $16.00M | $29.00M | $46.00M | $68.00M | $88.00M | $84.00M | $139.00M | $156.00M | $223.00M | $159.00M | $260.00M | $296.00M |
| QoQ Change | — | — | — | — | +66.7% | +220.0% | +81.3% | +58.6% | +47.8% | +29.4% | -4.5% | +65.5% | +12.2% | +42.9% | -28.7% | +63.5% | +13.8% |
| YoY Change | — | — | — | — | — | — | — | >999% | >999% | +450.0% | +189.7% | +202.2% | +129.4% | +153.4% | +89.3% | +87.1% | +89.7% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's camzyos — total revenues?
- Bristol-Myers Squibb (BMY) reported camzyos — total revenues of $296.00M in Q3 2025.
- How has Bristol-Myers Squibb's camzyos — total revenues changed year-over-year?
- Bristol-Myers Squibb's camzyos — total revenues increased by 89.7% year-over-year, from $156.00M to $296.00M.
- What is the long-term trend for Bristol-Myers Squibb's camzyos — total revenues?
- Over 2 years (2022 to 2024), Bristol-Myers Squibb's camzyos — total revenues has grown at a 400.8% compound annual growth rate (CAGR), from $24.00M to $602.00M.
- What does camzyos — total revenues mean?
- The total revenue earned from sales of the drug Camzyos.